375 related articles for article (PubMed ID: 17400655)
21. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
Wu M; Wallace MR; Muir D
J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
[TBL] [Abstract][Full Text] [Related]
22. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
23. TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia.
Mora R; Abschuetz A; Kees T; Dokic I; Joschko N; Kleber S; Geibig R; Mosconi E; Zentgraf H; Martin-Villalba A; Régnier-Vigouroux A
Glia; 2009 Apr; 57(5):561-81. PubMed ID: 18942750
[TBL] [Abstract][Full Text] [Related]
24. Natural history of neurofibromatosis 1-associated optic nerve glioma in mice.
Bajenaru ML; Garbow JR; Perry A; Hernandez MR; Gutmann DH
Ann Neurol; 2005 Jan; 57(1):119-27. PubMed ID: 15622533
[TBL] [Abstract][Full Text] [Related]
25. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
26. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
Solga AC; Gianino SM; Gutmann DH
Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450
[TBL] [Abstract][Full Text] [Related]
27. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
[TBL] [Abstract][Full Text] [Related]
28. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
29. Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.
Simmons GW; Pong WW; Emnett RJ; White CR; Gianino SM; Rodriguez FJ; Gutmann DH
J Neuropathol Exp Neurol; 2011 Jan; 70(1):51-62. PubMed ID: 21157378
[TBL] [Abstract][Full Text] [Related]
30. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
31. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
[TBL] [Abstract][Full Text] [Related]
32. Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells.
Thomas SL; Deadwyler GD; Tang J; Stubbs EB; Muir D; Hiatt KK; Clapp DW; De Vries GH
Biochem Biophys Res Commun; 2006 Sep; 348(3):971-80. PubMed ID: 16908010
[TBL] [Abstract][Full Text] [Related]
33. CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).
Held-Feindt J; Hattermann K; Müerköster SS; Wedderkopp H; Knerlich-Lukoschus F; Ungefroren H; Mehdorn HM; Mentlein R
Exp Cell Res; 2010 May; 316(9):1553-66. PubMed ID: 20184883
[TBL] [Abstract][Full Text] [Related]
34. Nf1 haploinsufficiency augments angiogenesis.
Wu M; Wallace MR; Muir D
Oncogene; 2006 Apr; 25(16):2297-303. PubMed ID: 16288202
[TBL] [Abstract][Full Text] [Related]
35. The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.
Sliwa M; Markovic D; Gabrusiewicz K; Synowitz M; Glass R; Zawadzka M; Wesolowska A; Kettenmann H; Kaminska B
Brain; 2007 Feb; 130(Pt 2):476-89. PubMed ID: 17107968
[TBL] [Abstract][Full Text] [Related]
36. An alpha5beta1 integrin inhibitor attenuates glioma growth.
Färber K; Synowitz M; Zahn G; Vossmeyer D; Stragies R; van Rooijen N; Kettenmann H
Mol Cell Neurosci; 2008 Dec; 39(4):579-85. PubMed ID: 18804537
[TBL] [Abstract][Full Text] [Related]
37. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning.
Yu X; Chen S; Potter OL; Murthy SM; Li J; Pulcini JM; Ohashi N; Winata T; Everett ET; Ingram D; Clapp WD; Hock JM
Bone; 2005 May; 36(5):793-802. PubMed ID: 15804420
[TBL] [Abstract][Full Text] [Related]
39. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH
Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]